Prostaglandins in Peptic Ulcer Disease: An Overview of Current Status and Future Directions

Drugs

Volumn 32, Issue 5, 1986, Pages 445-457

  Sontag, Stephen J ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTACID AGENT; ARBAPROSTIL; CIMETIDINE; ENPROSTIL; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; RANITIDINE; TOBACCO SMOKE;

ADVERSE DRUG REACTION; CELL PROTECTION; DIGESTIVE SYSTEM; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; PEPTIC ULCER; PREVENTION; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE; STOMACH; STOMACH ACID SECRETION; STOMACH EROSION; SURVEY; THERAPY; WOUND HEALING;

ANIMAL; GASTRIC MUCOSA; HUMAN; PEPTIC ULCER; PROSTAGLANDINS;

EID: 0023031955     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198632050-00003     Document Type: Review

References (89)

1. Cytoprotection by a synthetic prostaglandin against ethanol-induced gastric mucosal damage: a double-blind endoscopic study in human subjects
2. 1
3. Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease
4. Bioconversion of arachidonic acid in the human gastrointestinal tract
5. The clinical use of gastric function tests
6. The isolation of prostaglandin F from sheep prostate glands
7. Anti-ulcer therapy: past to present
8. 1 analog, in the treatment of duodenal ulcers: a multicenter double-blind study
9. Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer: a multicenter double-blind controlled trial
10. Prostaglandin cytoprotection of gastric mucosa
11. 2
12. 1 methyl analogue)
13. Protection against aspirin-induced antral and duodenal damage with enprostil: a double-blind endoscopic study
14. Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels
15. Is peptic ulcer a prostaglandin deficiency disease?
16. Effects of E prostaglandins on canine gastric potential difference
17. Gastrointestinal cytoprotective effects of misoprostol: clinical efficacy overview
18. Effect of cigarette smoking on gastric secretory responses
19. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers
20. Augmentation of prostaglandin production by linoleic acid in man
21. Cigarettes, alcohol, coffee and peptic ulcer
22. 2: an endoscopic study
23. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease or treatment?
24. Reduction by enprostil of aspirin induced bleeding from human gastric mucosa
25. Overview of clinical safety with misoprostol
26. Arachidonic acid protection of rat gastric mucosa against ethanol injury
27. 2 on gastric mucosal bleeding caused by aspirin
28. 1 analogue on aspirin-induced gastric bleeding and secretion
29. Recurrent ulcer after successful treatment with cimetidine or antacid
30. Morphology of rat gastric mucosal damage, defense, and restitution in the presence of luminal ethanol
31. Mechanism of gastric mucosal cytoprotection by prostaglandins
32. Effect of various antacids on the hydrogen ion concentration of the gastric content
33. Actions of nonsteroid anti-inflammatory compounds on gastric mucosal integrity and prostaglandin formation in healthy subjects and peptic ulcer patients
34. 2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man
35. Ranitidine in duodenal ulcer: incidence of healing and effect of smoking
36. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid
37. Biochemical studies of human semen. II. The action of semen on the human uterus
38. 1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing
39. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects
40. 2 and cimetidine on mucosal blood flow and oxygen consumption in dog ex vivo gastric chamber
41. Role of blood flow in gastric and duodenal mucosal injury in the rat
42. FDA GI Advisory Committee Summary
43. 2 synthesis — possible mechanism to explain its effective cytoprotective properties
44. Effect of paracetamol and milk on aspirin induced gastric erosions in man
45. Prostaglandins in commercial milk preparations: their effect in the prevention of stress induced gastric ulcer
46. 2
47. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms
48. Duodenal ulcer
49. Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking
50. Prostaglandins and the arachidonic acid cascade
51. A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in outpatients
52. Active smoking depresses prostaglandin synthesis in human gastroduodenal mucosa
53. A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients
54. 2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation
55. Diseases of the stomach
56. Cytoprotection by prostaglandins
57. Cytoprotection by prostaglandin occurs in spite of penetration of absolute ethanol into the gastric mucosa
58. Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury
59. Inhibition of gastric secretion by prostaglandins
60. 3
61. Concentrations of prostaglandin A-, E-, and F-like substances in gastric mucosa of normal subjects and of patients with various gastric diseases
62. Human proximal versus distal duodenal bicarbonate secretion: effect of endogenous prostaglandin synthesis
63. 2
64. Overall safety of enprostil in clinical studies
65. Gastric protection by misoprostol against 1300mg of aspirin
66. Gastric and duodenal ulcer: medical cure by an efficient removal of gastric juice corrosion
67. Duodenal mucosa synthesis of prostaglandins in duodenal ulcer disease
68. Predictors of duodenal ulcer healing and relapse
69. Effect of nicotine on gastric mucosal blood flow and acid secretion
70. Prostaglandins and the Universal Soldier
71. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer
72. Misoprostol in the treatment of duodenal ulcer a multicenter double-blind, placebo controlled study
73. Comparison of enprostil and placebo in active duodenal ulcer
74. 2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study
75. On the specific vaso-dilating and plain muscle stimulating substances from accessory genital gland in man and certain animals (prostaglandin and vesiglandin)
76. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins
77. 1 analogue (CL115,574)III: effects of gastric acid and mucus secretion in man
78. 1
79. 2) on human gastric secretion
80. Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma